Literature DB >> 10927779

Smoking cessation and risk of age-related cataract in men.

W G Christen1, R J Glynn, U A Ajani, D A Schaumberg, J E Buring, C H Hennekens, J E Manson.   

Abstract

CONTEXT: Although cigarette smoking has been shown to be a risk factor for age-related cataract, data are inconclusive on the risk of cataract in individuals who quit smoking.
OBJECTIVE: To examine the association between smoking cessation and incidence of age-related cataract.
DESIGN: Prospective cohort study conducted from 1982 through 1997, with an average follow-up of 13.6 years. SETTING AND PARTICIPANTS: A total of 20,907 US male physicians participating in the Physicians' Health Study I who did not have a diagnosis of age-related cataract at baseline and had reported their level of smoking at baseline. MAIN OUTCOME MEASURES: Incident age-related cataract defined as self-report confirmed by medical record review, diagnosed after study randomization and responsible for vision loss to 20/30 or worse, and surgical extraction of incident age-related cataract, in relation to smoking status and years since quitting smoking.
RESULTS: At baseline, 11% were current smokers, 39% were past smokers, and 50% were never smokers. Average reported cumulative dose of smoking at baseline was approximately 2-fold greater in current than in past smokers (35.8 vs 20.5 pack-years). Two thousand seventy-four incident cases of age-related cataract and 1193 cataract extractions were confirmed during follow-up. Compared with current smokers, multivariate relative risks (RRs) of cataract in past smokers who quit smoking fewer than 10 years, 10 to fewer than 20 years, and 20 or more years before the study were 0.79 (95% confidence interval [CI], 0.64-0.98), 0.73 (95% CI, 0.61-0.88), and 0.74 (95% CI, 0.63-0.87), respectively, after adjustment for other risk factors for cataract and age at smoking inception. The RR for never smokers was 0.64 (95% CI, 0.54-0.76). The reduced risk in past smokers was principally due to a lower total cumulative dose (RR of cataract for increase of 10 pack-years of smoking, 1.07; 95% CI, 1.04-1.10). A benefit of stopping smoking independent of cumulative dose was suggested in some analyses. Results for cataract extraction were similar.
CONCLUSION: These prospective data indicate that while some smoking-related damage to the lens may be reversible, smoking cessation reduces the risk of cataract primarily by limiting total dose-related damage to the lens. JAMA. 2000;284:713-716

Entities:  

Mesh:

Year:  2000        PMID: 10927779     DOI: 10.1001/jama.284.6.713

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  12 in total

Review 1.  Prevention strategies for age related cataract: present limitations and future possibilities.

Authors:  N G Congdon
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

2.  A population based case-control study of cataract and inhaled corticosteroids.

Authors:  L Smeeth; M Boulis; R Hubbard; A E Fletcher
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

3.  Smoking and the ophthalmologist.

Authors:  M Belkin
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

Review 4.  Lifestyle exposures and eye diseases in adults.

Authors:  Barbara E K Klein; Ronald Klein
Journal:  Am J Ophthalmol       Date:  2007-10-18       Impact factor: 5.258

5.  Knowledge about the relationship between smoking and blindness in Canada, the United States, the United Kingdom, and Australia: results from the International Tobacco Control Four-Country Project.

Authors:  Ryan David Kennedy; Marlee M Spafford; Carla M Parkinson; Geoffrey T Fong
Journal:  Optometry       Date:  2011-05

6.  Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women.

Authors:  William G Christen; Robert J Glynn; Emily Y Chew; Christine M Albert; JoAnn E Manson
Journal:  Ophthalmic Epidemiol       Date:  2016-01-20       Impact factor: 1.648

7.  Ophthalmic epidemiology in Europe: the "European Eye Epidemiology" (E3) consortium.

Authors:  Cécile Delcourt; Jean-François Korobelnik; Gabriëlle H S Buitendijk; Paul J Foster; Christopher J Hammond; Stefano Piermarocchi; Tunde Peto; Nomdo Jansonius; Alireza Mirshahi; Ruth E Hogg; Lionel Bretillon; Fotis Topouzis; Gabor Deak; Jakob Grauslund; Rebecca Broe; Eric H Souied; Catherine Creuzot-Garcher; José Sahel; Vincent Daien; Terho Lehtimäki; Hans-Werner Hense; Elena Prokofyeva; Konrad Oexle; Jugnoo S Rahi; Phillippa M Cumberland; Steffen Schmitz-Valckenberg; Sascha Fauser; Geir Bertelsen; Carel Hoyng; Arthur Bergen; Rufino Silva; Sebastian Wolf; Andrew Lotery; Usha Chakravarthy; Astrid Fletcher; Caroline C W Klaver
Journal:  Eur J Epidemiol       Date:  2015-12-19       Impact factor: 8.082

8.  Is the variant c.422+90G → A in intron 4 of indoleamine 2, 3 -dioxygenase (IDO) gene related to age related cataracts?

Authors:  M Mamata; G Sridhar; K Ravi Kumar Reddy; T Nagaraju; T Padma
Journal:  Mol Vis       Date:  2011-05-05       Impact factor: 2.367

9.  Customized Clinical Practice Guidelines for Management of Adult Cataract in Iran.

Authors:  Zhaleh Rajavi; Mohammad Ali Javadi; Narsis Daftarian; Sare Safi; Farhad Nejat; Armin Shirvani; Hamid Ahmadieh; Saeid Shahraz; Hossein Ziaei; Hamidreza Moein; Behzad Fallahi Motlagh; Sepehr Feizi; Alireza Foroutan; Hassan Hashemi; Seyed Javad Hashemian; Mahmoud Jabbarvand; Mohammad Reza Jafarinasab; Farid Karimian; Hossein Mohammad-Rabei; Mehrdad Mohammadpour; Nader Nassiri; Mahmoodreza Panahi-Bazaz; Mohammad Reza Rohani; Mohammad Reza Sedaghat; Kourosh Sheibani
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

10.  Risk Factors for Cataracts Treated Surgically in Postmenopausal Women.

Authors:  Sarah Floud; Hannah Kuper; Gillian K Reeves; Valerie Beral; Jane Green
Journal:  Ophthalmology       Date:  2016-06-07       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.